Dft. STE-H&» S. BESZEiJESDft. STE-H & »S. BESZEiJES
3 DAOHAU bsi MÜHCHEN3 DAOHAU to MÜHCHEN
Afci HcIDEVIEQ ?.
TELEPHON: DACHAU 43 71Afci HcIDEVIEQ?.
 TELEPHONE: DACHAU 43 71
P 6?IP 6? I
B e ω c b rB e ω c b r
zur Patentomieldungfor patent application
I.S.P. S.p.A.Trossano s/T.? (Hilano), ItalienI.S.P. Spa.Trossano s / T.? (Hilano), Italy
"betreffend"concerning
Inhalntor1 fib? pf:lvori*örnip;e Sv;batanaoaInhaler1 fib? pf: lvori * örnip; e Sv; batanaoa
Die Erfindung betrifft einen Inhalator sur Yera'breisvon pulverfönaigon AraneinittelnoThe invention relates to an inhaler sur Yera'breis from pulverfönaigon Araneinmittelo
IjS sind bereits Inhalatorea lator Vcrvxenclujig einerelastischen i'u'ape und einer !Tadel zun Durcb-Gtoßen einereino Arzneimittolsubstrma enthaltenden Kapsel.bekannt. !21all';cT;ioinon iat aber deren Arbaiten nicht völlig zufriedenstellend, ihre· Ausführung ziemlich, koapliüiex't und der Platzbedarfdurch ihre Ab-nenr.vinsen ^roß.Inhaler reactors with an elastic tape and a reprimand for pushing a capsule containing a drug substrate are already known. ! 21 all '; cT ; ioinon iat but their work is not completely satisfactory, their execution fairly, koapliüiex't and the space required by their ab-nenr.vinsen ^ roß.
—-
7411543 05.OZ767411543 05.OZ76
OH.CTEPHAN Q. BESZEDEb PATENTANWALTOH. CTEPHAN Q. BESZEDEb PATENT ADVOCATE
806 DACHAU bei MÖNCHEN806 DACHAU near MÖNCHEN
POSTFACH 1.68PO Box 1.68
AM HEIDEWEG 2AM HEIDEWEG 2
Konto-Nr. 136S 7tAccount no. 136S 7t
Bankkonto Nr. GO 637 bei der Kreis- und Stadtsparkasse Dacheil'iAdersdorf (BLZ 700 515 40)Bank account no.GO 637 at the Kreis- und Stadtsparkasse Dacheil'iAdersdorf (bank code 700 515 40)
22. Oktober 1975 G 74 115 43.8 P 672October 22, 1975 G 74 115 43.8 P 672
Die Bauteile 1 und 2 beziehungsweise 10 und 21 können alsgegenüber den anderen Bestandteilen des Inhalators beweglich angesehen werden, wie es aus einem Vergleich der Figuren 1und 4 hervorgeht.The components 1 and 2 or 10 and 21 can be viewed as movable with respect to the other components of the inhaler, as can be seen from a comparison of FIGS. 1 and 4.
Der Inhalator umfaßt ferner Anschlagmuffen 7i 7'» welchemit je einem inneren Anschlag 20, 20', von welchen jedermit einem Anschlag 19 beziehungsweise 19' des jeweiligen Perforiernadelhalterelementes2 beziehungsweise 2' zusammenwirkt, versehen sind, wie es insbesondere in Figur 1 dargestelltist. Die Anschlagmuffen 7, 71 sind durch Verklebenoder durch Rändelungen, wie es in Figur 3 dargestellt ist, an die bei 17 aneinandergeschraubten Kapselhalterteile 3j 4, welcheeinen Hohlraum 8 zur Aufnahme der Kapsel 16 bilden, starr befestigt. Beide Kapselhalterteile 3» 4 haben je einen Durchtritt18, 18', welche den Durchgang der Perforiernadeln 5, 51und von Luft gestatten. Um die Perforiernadel5,5' von derKapsel 16 getrennt zu halten, sind zwei Rückholfedern 21, 21' an den manteiförmigen Enden jedes Perforiernadelhalterelementes2, 21 in je einem ringförmigen Hohlraum zur Aufnahme vonzylindrischen Rückholfedern 21 beziehungsweise 21' zusammengedrücktangeordnet, so daß die Rückholfedern 21 beziehungsweise 21' zwischen dem Boden des Rückholfederhaltehohlraumesund den Enden der Verlängerung des Perforiernadelhalterelementes2 beziehungsweise 21 arbeiten. 14 ist eine Aus-The inhaler further comprises stop sleeves 7i 7 '' which are each provided with an inner stop 20, 20 ', each of which interacts with a stop 19 or 19' of the respective perforating needle holder element 2 or 2 ', as shown in particular in FIG . The stop sleeves 7, 71 are rigidly attached by gluing or knurling, as shown in FIG. Both capsule holder parts 3 »4 each have a passage 18, 18 ', whichallow the passage of the perforating needles 5, 5 1 and air. In order to keep the perforating needle5, 5 'separated from the capsule 16, two return springs 21, 21' are arranged pressed together at the jacket-shaped ends of each perforating needle holder element 2, 21 in an annular cavity for receiving cylindrical return springs 21 and 21 ', respectively that the return springs 21 and 21 'work between the bottom of the return spring holding cavity and the ends of the extension of the perforating needle holder element 2 and 21 , respectively. 14 is an
7411543 05.01767411543 05.0176
Der Erfindung· liegt die Aufgabe zugrunde, einenüber den angegebenen Stand der Technik vorbesserten Inhalatorvon einfacher Ausführung, rascher und sicherer Wirkung und verringerten Abmessungen zu schaffen.The invention · is based on the object of aInhaler improved over the stated state of the artof simple execution, quick and safe operation and reduced dimensions.
Die Erfindung geht von einem Inhalator für in einer mittels einer Perforiernadel zu durchstoßenden Kapsel enthaltenepi/lvürföraige Substanzen, welche mit Hilfe einerPumpe zu verteilen sind, mit eineia oberen Teil, an dessenEndQ die pulverförmige Substanz austritt, einem mittlerenTeil und einem unteren Teil aum Anschließen an die Pumpe aus. Die oben angeführte Problemstellung wird hierbei dadurchgelöst, daß der Inhalator durch ein ortsfestes mittleres Element als mittleren Teil, das von zwei, vorzugsx<reisedurch Verschrauben beziehungsweise eine Bajonettkupplung, miteinander zu verbindenden Kapselhalterteilen gebildet istund einen Hohlraum zur Aufnahme der Kapsel aufweist, und zwei gegeneinander bewegliche Perforiernadelhalterelementeim oberen Teil beziehungsweise unteren Teil, welche in die beiden. Kapselhalterteile gegen die Wirkung von Rückholfedernteleskopartig hineinbewegbar sind, gekennzeichnet ist.The invention relates to an inhaler for contained in a capsule to be pierced by means of a perforating needlepi / lvüröraige substances, which with the help of aPump are to be distributed, with an upper part on itsEndQ the powdery substance emerges, a middle onePart and a lower part for connecting to the pump. The above-mentioned problem is thereby solvedsolved that the inhaler through a stationary middle element as the middle part, which of two, preferred x <travelsis formed by screwing or a bayonet coupling to be connected to each other capsule holder partsand has a cavity for receiving the capsule, and two perforating needle holder elements which are movable relative to one anotherin the upper part and lower part, which in the two. Capsule holder parts against the action of return springsare telescopically movable in, is characterized.
Gemäß einer Ausgestaltung des Erfindungsgedankens ist es zweckmäßig, daß die beiden Kapselhalterteile des mittlerenElementes mit Anschlagmuffen nebst je einem inneren Anschlag,von welchen jeder in der Ruhestellung mit einem Anschlag des jeweiligen Perforiernadelhalterelementes inAnlage zu bringen ist, verbunden sind, vorzugsweise durch Verkleben beziehungsweise Reibungsverriegelung, und in derArbeitsstellung beziehungsweise beim Durchstoßen der Kapsel der Anschlag des jeweiligen Perforiernidelhalterelementesmit dem jeweiligen Kapselhalterteil in Anlage zu bringen ist.According to one embodiment of the inventive concept, it is expedient that the two capsule holder parts of the middleElement with stop sleeves plus one inner stop each,each of which in the rest position with a stop of the respective perforating needle holder element inIs to bring plant, are connected, preferably by gluing or friction locking, and in theWorking position or the stop of the respective perforating pin holder element when the capsule is piercedis to be brought into contact with the respective capsule holder part.
7411543 Q5.02J67411543 Q5.02J6
Eej ist auch gemäß einer weiteren Ausgestaltung vorteilhaft,daß die Roibun^sVerriogelung der Perforiorcad 1-halterelcsentomit dera oberen Clement beziehungsweisedem iliiaehluiostück des unteren üloLientoo für die Pu.ipc üox-jiodie Kupplun^sverriegelung der Anschlagmuffon. mit den Kapse1haltorteilen durch Hilcporippen mit Öägezühnen gebildetEej is also advantageous according to a further embodiment,that the Roibun ^ sVerriogelung the Perforiorcad 1-halterelcsentowith dera upper Clement respectivelythe iliiaehluio piece of the lower üloLientoo for the Pu.ipc üox-jiothe coupling lock of the stop muffon. with the caps 1holder parts formed by Hilcporippen with Öägezhnen
Vorzucstireise ist das untere Element des Inhalators vonsolcher Porin, daß bei ITichtp.etorauch der Inhalatorkorper innerhalbder Pumpe lamgekehrt» zweckmäßigerw iao bei aurrechterStellung der Purape nach unton, eingesetzt v/erdcn kann,wodurch eine beträchtliche Verrincei-uns des PlatKbodarfcsnebst Steigerung der Gebrauchsfähi^keit und ein gefällico^kompaktes Aussehen des Gerätes erreicht werden.Pre-travel is the lower element of the inhaler fromsuch a porin that at ITichtp.etorauch the inhalator body is withinthe pump turned upside down »more expediently w iao with aurgerePosition of the Purape towards Unton, can be inserted,thereby making a considerable verrincei-us des PlatKbodarfcsin addition to an increase in usability and a pleasing qualitycompact appearance of the device can be achieved.
Nach einer besonders vorteilhaften Ausführungsforn der Erfindung ist daher das Profil der zylindrischen Oberfläche dosunteren Teiles des Inhalators glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung, an welchen das Mundstück der Pumpe durch Reibungsverriogolung in Anlage su bringen ist, unterbrochen. Dabei sind vorzugsweice die Berührungstellen der zylindrischen Oberfläche des unteren Teiles des Inhalator^ mit der geraden Oberfläche des Vorsprunges Verriegelungsstellenzur Reibungsverriegelung mit der Pumpe im gebrauchsbereiten Zustand des Inhalators. Auch sind vorzugsweisedie Berührunjsstellen der zylindrischen Oberfläche des unteren Teiles des Inhalators mit der gekrümmten Oberflächedes V.orsprung^s Verriegelungsstellcn zur Reibungsverriegeluugmit der Punpe im Ruhezustand des Inhalators.According to a particularly advantageous embodiment of the Erfinding is therefore the profile of the cylindrical surface doslower part of the inhaler smooth or polished and uniform and of a protrusion on which the mouthpart of the pump is brought into the system by frictional locking, interrupted. Touch is preferredmake the cylindrical surface of the lower part of the inhaler ^ locking points with the straight surface of the projectionfor frictional locking with the pump when the inhaler is ready for use. Also are preferredthe contact points of the cylindrical surface of the lower part of the inhaler with the curved surfaceof the protrusion of the locking position for friction lockingwith the pump while the inhaler is at rest.
Der erfindungsgemäße Inhalator wird an Hand des folgendenAusführungsbeispieles in Verbindung mit den beiliegenden Zeichnungen näher erläutert.The inhaler of the present invention is illustrated by the followingEmbodiment explained in more detail in connection with the accompanying drawings.
7411543 05.02.767411543 02/05/76
_ 4- —
Hierbei sind:_ 4- -
 Here are:
Figur 1 ein Lü;i;;cschnitt durch einen erfindun;;s~graiißon Inhalator in GruMctellui'^ beziehungsweisevor Ingebrauchnahme,Figure 1 a Lü; i ;; c section through an invention ;; s ~gray inhaler in GruMctellui '^ respectivelybefore use,
Figur 2 oin Schnitt längs der Linie II II vonFigure 2 o in section along the line II II of
Figur 1,Figure 1,
Figur 3 ein in Figur 1 enthaltener Kupplungsteil des erfindungGgemäßen Inhalators in demgegenübervergrößerter Darrteilung undFIG. 3 shows a coupling part of the inhaler according to the invention contained in FIG. 1 in contrastenlarged presentation and
Figur 4 der Inhalator vor Figur 1 nach Ingebrauchnahmebeziehungsweise nach den Durchstoßen einer darin enthaltenen Kapsel»FIG. 4 shows the inhaler in front of FIG. 1 after it has been usedor after piercing a capsule contained therein »
Gemäß den Figuren 1 und 4- umfaßt der Inhalator ein oberes Element 1, aus welchem ein von einer Kapsel 16 nach dem Durchstoßenverteiltes Pulver zum Ausströmen gebracht wird, und ein Anschlußstück beziehungsweise Mundstück 10 zum Anschließen desInhalators an eine herkömmliche Pumpe 15« Da die Pumpe 15 einegroße Zahl von Ausführungen haben kann, wird sie nicht näher beschrieben und ist nur schematisch dargestellt. In oberen Element1 beziehungsweise im Anschlußstück 10 sind Perforiernadelh^lterelementebeziehungsweise -anschlußstüclie 2, 2' befestigt, wobei die Verbindung durch Verkleben oder durch Kündelungen 13tderen Profile gemäß Figur 3 eine iieibungsverriegelung bewirken,herbeigeführt wird, wie uus Figur 2 hervorgeht, ist die Perforiernadel5 beziehungsweise 51 in dos Porforiornadelhultcrolcment2 beziehungsweise 2' hineingeschoben und wird durch vier radiale Rippen 9 beziehungsweise 91» welche neben dem Haltender Perforiernadel 5 beziehungsweise 5* den Durchgang von Luftgestatten, gehalten.According to FIGS. 1 and 4, the inhaler comprises an upper element 1, from which a powder distributed by a capsule 16 after being pierced is made to flow out, and a connector or mouthpiece 10 for connecting the inhaler to a conventional pump 15 Pump 15 can have a large number of designs, it is not described in detail and is only shown schematically. Perforiernadelh ^ lterelemente or -anschlussstüclie 2, 2 'are attached in the upper element 1 or in the connection piece 10, the connection being brought about by gluing or by means of bundles 13t whose profiles according to FIG Perforating needle 5 or 51 is pushed into dos Porforiornadelhultcrolcment 2 or 2 'and is held by four radial ribs 9 or 91 ' which, in addition to holding the perforating needle 5 or 5 *, allow air to pass through.
7411543 05.02.767411543 02/05/76
trittsöffnung für die Arzneimittel sub stanz und 22 der Einlaßfür die durch die Pumpe 15 gepumpte Luft·opening for the drug substance and 22 the inletfor the air pumped by the pump 15
AOAO
Die Rippen 9» 91 legen sowohl Luftdurchgänge fest als auchverbinden sie die Perforiernadelhalterung mit dem Körper des betreffenden Perforiernadelhalterelementes 2 beziehungsweise2'.The ribs 9 »91 both define air passages and connect the perforating needle holder to the body of the relevant perforating needle holder element 2 or 2 '.
In Figur 1 sind die inneren Anschläge 20, 20' der Anschlagmuffen7» 71 in Anlage mit den Anschlägen 19» 19' derPerforiernadelhalterelemente 2, 21 gezeigt, während sich inFigur 2 die Anschläge 19* 19' der Perforiernadelhalterelemente2, 21 mit den rohrförmigen Verlängerungen 6, 61 derKapselhalterelemente J, 4 in Anlage befinden.In Figure 1, the internal stops 20, 20 'of the stop sleeves 7 »71 into abutment with the stops 19' 19 'of the Perforiernadelhalterelemente 2 shown 21, while in Figure 2, the stops 19 * 19' of the Perforiernadelhalterelemente 2, 21 are in contact with the tubular extensions 6, 61 of the capsule holder elements J, 4.
In den Figuren 1 und 4 ist das Profil der zylindrischenOberfläcne des unteren Teiles 10 des Inhalatorkörpers, welcher durch Reibungsverriegelung mit der Pumpe 15 von geeignetenAbmessungen verbunden ist, glatt beziehungsweise poliert und gleichförmig und von einem Vorsprung 11, dessen Berührungsstellen 12, 12' mit der zylindrischen Oberfläche des unterenTeiles 10 des Inhalatorkörpers die Anschlagstellen zur Reibungsverriegelung mit der Pumpe 15 darstellen, wenn der Inhalatorgebrauchsbereit ist beziehungsweise nicht gebraucht wird, unterbrochen.In Figures 1 and 4, the profile is the cylindricalSurface of the lower part 10 of the inhaler body, which by frictional locking with the pump 15 of suitableDimensions is connected, smooth or polished and uniform and by a projection 11, the points of contact 12, 12 'with the cylindrical surface of the lowerPart 10 of the inhaler body represent the stop points for frictional locking with the pump 15 when the inhaleris ready for use or is not used, interrupted.
Die Arbeitsweise des Inhalators ist wie folgt:The way the inhaler works is as follows:
Zunächst wird der innerhalb der Pumpe 1.5 umgekehrt, zweckmäßigerweise bei aufrechter Stellung der Pumpe 15 nachunten, angeordnete Inhalatorkörper von der letzteren entfernt und innerhalb derselben durch Reibungsverriegelung in seinermit der Pompe 15 gleichsinnigen Anordnung, zweckmäßigerweisein aufrechter Stellung bei aufrechter Stellung der Pumpe 15, mit der Pumpe 15 verbundene Dann wird der Kapselhalterteil 4First, the inside of the pump 1.5 is reversed, expediently with the pump 15 in an upright positionbelow, located inhaler body removed from the latter and within the same by friction locking in itswith the Pompe 15 arrangement in the same direction, expedientlyin the upright position with the upright position of the pump 15, connected to the pump 15 Then the capsule holder part 4
— 1 —- 1 -
7411543 05.01767411543 05.0176
vom Kapselhalterteil 3 abgeschraubt und die Kapsel 16 eingesetzt,worauf das obere Element 1 und das Anschlußstück 10 des unteren Teiles gegeneinanderbewegt werden, das heißt eineVerkürzung beziehungsweise Stauchung des Inhalators längs der Pfeile A und B hervorgerufen wird, was zu zwei diametralentgegengesetzten Einstichen in die Kapsel 16 führt. Daher genügt es, die Pumpe 15 zu drücken, um den pulverförmigen Inhaltder Kapsel 16 in einsn Hohlraum von Mensch oder Tier, wie Nasenhöhlen beziehungsweise andere Hohlräume des menschlichenoder tierischen Körpers, einzuführen.unscrewed from the capsule holder part 3 and inserted the capsule 16,whereupon the upper element 1 and the connecting piece 10 of the lower part are moved towards one another, that is to say oneShortening or compression of the inhaler along the arrows A and B is brought about, resulting in two diametricalsopposite punctures in the capsule 16 leads. It is therefore sufficient to press the pump 15 to dispense the powdery contentthe capsule 16 in a cavity of humans or animals, such as nasal cavities or other cavities of the humanor animal body.
Aus dem Obigen geht die große Vereinfachung, welchedurch den erfindungsgemäßen Inhalator mit sehr wenigen Teilen erreicht wurde, weswegen der Zusammenbau nur mit sehrgeringen Kosten verbunden ist, hervor.From the above goes the great simplification, whichwas achieved by the inhaler according to the invention with very few parts, which is why the assembly only with verylow cost.
/11/ 11
SchutzansprücheProtection claims
7411543 05.01767411543 05.0176
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| IT2257673AIT986056B (en) | 1973-04-04 | 1973-04-04 | INSUFFLATOR FOR POWDER-SHAPED MEDICATIONS | 
| IT2569873AIT1045851B (en) | 1973-06-22 | 1973-06-22 | Inhaler for administering powdered medicaments - offers long term trouble free efficiency from particularly simple, inexpensive construction | 
| Publication Number | Publication Date | 
|---|---|
| DE7411543Utrue DE7411543U (en) | 1976-02-05 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| DE2415961APendingDE2415961A1 (en) | 1973-04-04 | 1974-04-02 | INHALER FOR POWDERED SUBSTANCES | 
| DE7411543UExpiredDE7411543U (en) | 1973-04-04 | 1974-04-02 | INHALER FOR POWDERED SUBSTANCES | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| DE2415961APendingDE2415961A1 (en) | 1973-04-04 | 1974-04-02 | INHALER FOR POWDERED SUBSTANCES | 
| Country | Link | 
|---|---|
| US (1) | US3906950A (en) | 
| JP (1) | JPS5048782A (en) | 
| BE (1) | BE813143A (en) | 
| CH (1) | CH569486A5 (en) | 
| DE (2) | DE2415961A1 (en) | 
| FR (1) | FR2224175B1 (en) | 
| GB (1) | GB1436813A (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4069819A (en)* | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device | 
| IT1017153B (en)* | 1974-07-15 | 1977-07-20 | Isf Spa | APPARATUS FOR INHALATIONS | 
| YU41046B (en)* | 1974-08-22 | 1986-10-31 | Schering Ag | Medicine inholating device | 
| GB1521000A (en)* | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device | 
| GB1562732A (en)* | 1976-02-10 | 1980-03-12 | Allen & Hanburys Ltd | Device for dispensing medicaments | 
| US4095596A (en)* | 1976-11-26 | 1978-06-20 | Smithkline Corporation | Nasal inhaler | 
| IT1116047B (en)* | 1979-04-27 | 1986-02-10 | Sigma Tau Ind Farmaceuti | DEVICE FOR THE QUICK INHALATION OF POWDER DRUGS BY PERSONS SUFFERING FROM ASTHMA | 
| US4446862A (en)* | 1979-10-30 | 1984-05-08 | Baum Eric A | Breath actuated devices for administering powdered medicaments | 
| DE3345722A1 (en)* | 1983-12-17 | 1985-06-27 | Boehringer Ingelheim KG, 6507 Ingelheim | INHALATOR | 
| US4620847A (en)* | 1984-06-01 | 1986-11-04 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances | 
| US4645487A (en)* | 1984-06-05 | 1987-02-24 | Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov | Device for administering powdered substances | 
| IT1222509B (en)* | 1987-08-17 | 1990-09-05 | Miat Spa | INSUFFLATOR FOR THE ADMINISTRATION OF DRUGS IN THE FORM OF PRE-DOSED POWDER IN OPERATIONS | 
| IT1228460B (en)* | 1989-02-23 | 1991-06-19 | Phidea S R L | DISPOSABLE INHALER WITH PRE-PERFORATED CAPSULE | 
| US6048857A (en)* | 1989-10-17 | 2000-04-11 | Ellinwood, Jr.; Everett H. | Dosing method of administering medicaments via inhalation administration | 
| IT1237118B (en)* | 1989-10-27 | 1993-05-18 | Miat Spa | MULTI-DOSE INHALER FOR POWDER DRUGS. | 
| DE4027391A1 (en)* | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | GAS-FREE INHALATION DEVICE | 
| US7628339B2 (en) | 1991-04-24 | 2009-12-08 | Novartis Pharma Ag | Systems and methods for controlling fluid feed to an aerosol generator | 
| US6540154B1 (en) | 1991-04-24 | 2003-04-01 | Aerogen, Inc. | Systems and methods for controlling fluid feed to an aerosol generator | 
| US5161524A (en)* | 1991-08-02 | 1992-11-10 | Glaxo Inc. | Dosage inhalator with air flow velocity regulating means | 
| DE4128295A1 (en)* | 1991-08-27 | 1993-03-04 | Pfeiffer Erich Gmbh & Co Kg | DISCHARGE DEVICE FOR FLOWABLE MEDIA | 
| DK198591D0 (en)* | 1991-12-10 | 1991-12-10 | Novo Nordisk As | APPARATUS | 
| EP0691864A4 (en)* | 1993-03-03 | 1996-07-03 | Tenax Corp | POWDER DRUG HOLDER, FOR INHALER | 
| US5388572A (en)* | 1993-10-26 | 1995-02-14 | Tenax Corporation (A Connecticut Corp.) | Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same | 
| US5388573A (en)* | 1993-12-02 | 1995-02-14 | Tenax Corporation | Dry powder inhalator medicament carrier | 
| US5488946A (en)* | 1994-03-01 | 1996-02-06 | Calhoun; Clifford A. | Emergency breathing device for opening cartridges | 
| JP3372105B2 (en)* | 1994-05-26 | 2003-01-27 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser | 
| AU3703895A (en)* | 1994-10-24 | 1996-05-15 | Oxford Biosciences Limited | Particle delivery | 
| US5901703A (en)* | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities | 
| JP3308425B2 (en)* | 1995-03-10 | 2002-07-29 | 株式会社ユニシアジェックス | Nasal administration device | 
| US5758637A (en)* | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods | 
| US6085740A (en) | 1996-02-21 | 2000-07-11 | Aerogen, Inc. | Liquid dispensing apparatus and methods | 
| US6428771B1 (en)* | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system | 
| US5823183A (en)* | 1995-08-02 | 1998-10-20 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | 
| US5988163A (en)* | 1995-08-02 | 1999-11-23 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament | 
| US5692496A (en)* | 1995-08-02 | 1997-12-02 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | 
| US6209538B1 (en) | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | 
| DE19533979A1 (en)* | 1995-09-14 | 1997-03-20 | Alfred Von Schuckmann | Device for the dosed, airborne delivery of substances | 
| JP3317827B2 (en)* | 1995-10-09 | 2002-08-26 | 株式会社ユニシアジェックス | Dosing device | 
| US6013050A (en)* | 1995-10-20 | 2000-01-11 | Powderject Research Limited | Particle delivery | 
| JP3328132B2 (en)* | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | Inhaler type dispenser | 
| AUPN976496A0 (en)* | 1996-05-10 | 1996-05-30 | Glaxo Wellcome Australia Ltd | Unit dose dispensing device | 
| AU3273497A (en)* | 1997-06-23 | 1999-01-04 | Marco Cecchini | Inhaling device | 
| JP3488620B2 (en)* | 1998-02-05 | 2004-01-19 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser | 
| JP3530004B2 (en)* | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser | 
| US6257233B1 (en)* | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use | 
| HK1042234A1 (en) | 1999-04-13 | 2002-08-09 | Nektar Therapeutics | Pulmonary administration of dry powder formulations for treating infertility | 
| EP2280020B1 (en)* | 1999-06-29 | 2016-02-17 | MannKind Corporation | Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine | 
| US9006175B2 (en)* | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination | 
| US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler | 
| US7464706B2 (en)* | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler | 
| US6235177B1 (en) | 1999-09-09 | 2001-05-22 | Aerogen, Inc. | Method for the construction of an aperture plate for dispensing liquid droplets | 
| JP4859320B2 (en)* | 1999-10-29 | 2012-01-25 | ネクター セラピューティックス | Dry powder composition having improved dispersibility | 
| DE19960459A1 (en)* | 1999-12-15 | 2001-06-21 | Pfeiffer Erich Gmbh & Co Kg | Media Donor | 
| US20010029947A1 (en)* | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders | 
| US7600511B2 (en) | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system | 
| US6948491B2 (en) | 2001-03-20 | 2005-09-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods | 
| US7971588B2 (en) | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator | 
| US8336545B2 (en) | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator | 
| US7100600B2 (en)* | 2001-03-20 | 2006-09-05 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers | 
| MXPA02010884A (en) | 2000-05-05 | 2003-03-27 | Aerogen Ireland Ltd | Apparatus and methods for the delivery of medicaments to the respiratory system. | 
| US6948494B1 (en)* | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use | 
| AU2001283546A1 (en) | 2000-08-14 | 2002-02-25 | Advanced Inhalation Research, Inc. | Inhalation device and method | 
| US6766799B2 (en)* | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device | 
| US6732944B2 (en) | 2001-05-02 | 2004-05-11 | Aerogen, Inc. | Base isolated nebulizing device and methods | 
| US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers | 
| GB2380410B (en)* | 2001-10-05 | 2003-11-19 | Alchemy Healthcare Ltd | Apparatus for the nasal or oral delivery of a medicament | 
| ES2363333T3 (en)* | 2001-11-14 | 2011-08-01 | Novartis Ag | AEROSOL SPRAYING DEVICE INCLUDING A CONNECTABLE BODY AND TERMINAL PIECE. | 
| ATE508735T1 (en) | 2001-12-19 | 2011-05-15 | Novartis Ag | PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES | 
| US7677467B2 (en) | 2002-01-07 | 2010-03-16 | Novartis Pharma Ag | Methods and devices for aerosolizing medicament | 
| MXPA04006629A (en) | 2002-01-07 | 2004-11-10 | Aerogen Inc | Devices and methods for nebulizing fluids for inhalation. | 
| WO2003059424A1 (en) | 2002-01-15 | 2003-07-24 | Aerogen, Inc. | Methods and systems for operating an aerosol generator | 
| ITMI20020078A1 (en)* | 2002-01-16 | 2003-07-16 | Fabrizio Niccolai | DEVICE USABLE IN THE TREATMENT OF RESPIRATORY TRACT AFFECTIONS | 
| ES2425392T3 (en) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartridge for an inhalation device | 
| JP3950738B2 (en)* | 2002-05-14 | 2007-08-01 | 株式会社 バイオアクティス | Nasal powder medicine administration device | 
| US6915962B2 (en) | 2002-05-20 | 2005-07-12 | Aerogen, Inc. | Apparatus for providing aerosol for medical treatment and methods | 
| US20040206350A1 (en)* | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber | 
| US7638138B2 (en) | 2003-02-21 | 2009-12-29 | Translational Research, Ltd. | Compositions for nasal administration of pharmaceuticals | 
| US7278982B2 (en) | 2003-03-27 | 2007-10-09 | Bioactis Limited | Powder medicine applicator for nasal cavity | 
| US8869794B1 (en)* | 2003-04-09 | 2014-10-28 | Novartis Pharma Ag | Aerosolization apparatus with capsule puncturing member | 
| EP1610850B2 (en) | 2003-04-09 | 2020-08-05 | Novartis AG | Aerosolization apparatus with air inlet shield | 
| US8616195B2 (en) | 2003-07-18 | 2013-12-31 | Novartis Ag | Nebuliser for the production of aerosolized medication | 
| US7338171B2 (en)* | 2003-10-27 | 2008-03-04 | Jen-Chuen Hsieh | Method and apparatus for visual drive control | 
| JP2007517892A (en)* | 2004-01-12 | 2007-07-05 | マンカインド コーポレイション | Methods for reducing serum proinsulin levels in type 2 diabetes | 
| WO2005079755A2 (en)* | 2004-02-12 | 2005-09-01 | Nektar Therapeutics | Interleukin-13 antagonist powders, spray-dried particles, and methods | 
| US20080090753A1 (en)* | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions | 
| US7267121B2 (en) | 2004-04-20 | 2007-09-11 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems | 
| US7290541B2 (en) | 2004-04-20 | 2007-11-06 | Aerogen, Inc. | Aerosol delivery apparatus and method for pressure-assisted breathing systems | 
| US7946291B2 (en) | 2004-04-20 | 2011-05-24 | Novartis Ag | Ventilation systems and methods employing aerosol generators | 
| CA2563365A1 (en)* | 2004-04-23 | 2005-11-03 | Mystic Pharmaceuticals, Inc. | Multiple unit dose drug delivery system | 
| US7727962B2 (en)* | 2004-05-10 | 2010-06-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder comprising new compositions of oligosaccharides and methods for their preparation | 
| US7723306B2 (en)* | 2004-05-10 | 2010-05-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation | 
| US7611709B2 (en)* | 2004-05-10 | 2009-11-03 | Boehringer Ingelheim Pharma Gmbh And Co. Kg | 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives | 
| KR20120131245A (en) | 2004-06-18 | 2012-12-04 | 노파르티스 아게 | Methods of Treatment of Endobronchial Infections | 
| JP4922762B2 (en) | 2004-08-10 | 2012-04-25 | 株式会社新日本科学 | Composition for nasal administration that is fast-acting and capable of high absorption | 
| JP5078014B2 (en) | 2004-08-20 | 2012-11-21 | マンカインド コーポレイション | Catalytic reaction of diketopiperazine synthesis. | 
| PL2322180T3 (en) | 2004-08-23 | 2015-10-30 | Mannkind Corp | Diketopiperazine salts for drug delivery | 
| GB0420513D0 (en)* | 2004-09-15 | 2004-10-20 | Optinose As | Powder delivery devices | 
| JP5188183B2 (en)* | 2004-11-10 | 2013-04-24 | シプラ・リミテッド | Inhaler | 
| US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof | 
| DK2594272T3 (en) | 2005-05-18 | 2018-09-03 | Horizon Orphan Llc | Aerosolized fluoroquinolones and their applications | 
| US7614429B2 (en)* | 2005-05-18 | 2009-11-10 | Symyx Solutions, Inc. | Apparatus and methods for storing and dispensing solid material | 
| CA2607747C (en) | 2005-05-25 | 2015-12-01 | Aerogen, Inc. | Vibration systems and methods | 
| CN104324366B (en) | 2005-09-14 | 2016-10-05 | 曼金德公司 | Method for preparation of drug based on improving the active agent affinity to crystalline microparticle surfaces | 
| US8084420B2 (en)* | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations | 
| US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations | 
| WO2007041481A1 (en)* | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations | 
| KR20080096809A (en) | 2006-02-22 | 2008-11-03 | 맨카인드 코포레이션 | Method for Improving Pharmaceutical Properties of Microparticles Containing Diketopiperazine and Active Agents | 
| DE102006010089A1 (en)* | 2006-02-24 | 2007-10-18 | Aha-Kunststofftechnik Gmbh | The dry powder inhaler | 
| CA2649109A1 (en)* | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations | 
| EP1844805A1 (en)* | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co.KG | Inhaler | 
| US7806117B2 (en)* | 2006-06-07 | 2010-10-05 | Shin Nippon Biomedical Laboratories, Ltd. | Peroral powder delivery device | 
| EP2029206A1 (en)* | 2006-06-16 | 2009-03-04 | Cipla Limited | Improved dry powder inhaler | 
| US8337817B2 (en) | 2006-12-26 | 2012-12-25 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application | 
| WO2008086413A2 (en)* | 2007-01-09 | 2008-07-17 | Mystic Pharmaceuticals, Inc. | Intranasal cartridge devices | 
| WO2008124522A2 (en)* | 2007-04-04 | 2008-10-16 | Biodel, Inc. | Amylin formulations | 
| GB2448183A (en) | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device | 
| US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers | 
| US8683995B2 (en) | 2007-05-16 | 2014-04-01 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers | 
| CN105776119B (en) | 2007-05-16 | 2019-04-23 | 神秘制药公司 | Composition unit dose dispensing container | 
| WO2008156586A2 (en)* | 2007-06-12 | 2008-12-24 | Alkermes, Inc. | Inhalation device for powdered substances | 
| EP2020249A1 (en)* | 2007-08-01 | 2009-02-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalator | 
| CN101801812B (en)* | 2007-09-14 | 2013-10-23 | 神秘制药公司 | Forming method of deep drawn container | 
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines | 
| CA2703597A1 (en)* | 2007-10-25 | 2009-04-30 | Novartis Ag | Powder conditioning of unit dose drug packages | 
| CA2711561A1 (en)* | 2008-01-04 | 2009-07-16 | Biodel, Inc. | Insulin formulations for insulin release as a function of tissue glucose levels | 
| EP2082769B1 (en) | 2008-01-24 | 2015-06-03 | Vectura Delivery Devices Limited | Inhaler | 
| ES2648196T3 (en) | 2008-02-07 | 2017-12-29 | The University Of Washington | Circumferential spray device | 
| BRPI0910875B8 (en)* | 2008-03-27 | 2021-06-22 | Mannkind Corp | dry powder inhalation system | 
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery | 
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system | 
| KR101628410B1 (en) | 2008-06-20 | 2016-06-08 | 맨카인드 코포레이션 | An interactive apparatus and method for real-time profiling of inhalation efforts | 
| TWI532497B (en) | 2008-08-11 | 2016-05-11 | 曼凱公司 | Ultra-fast use of insulin | 
| EP2341942A1 (en) | 2008-09-19 | 2011-07-13 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides | 
| US20110171312A1 (en)* | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Modified therapeutic peptides, methods of their preparation and use | 
| KR20160150110A (en) | 2008-10-07 | 2016-12-28 | 랩터 파마슈티컬스 인코포레이티드 | Aerosol fluoroquinolone formulations for improved pharmacokinetics | 
| US8629139B2 (en) | 2008-10-07 | 2014-01-14 | Mpex Pharmaceuticals, Inc. | Topical use of Levofloxacin for reducing lung inflammation | 
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents | 
| US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake | 
| DK2405963T3 (en) | 2009-03-11 | 2013-12-16 | Mannkind Corp | DEVICE, SYSTEM AND PROCEDURE FOR MEASURING RESISTANCE IN AN INHALATOR | 
| WO2010131486A1 (en)* | 2009-05-15 | 2010-11-18 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal pharmaceutical compositions with improved pharmacokinetics | 
| KR20180079458A (en) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | Diketopiperazine microparticles with defined specific surface areas | 
| WO2011013003A2 (en)* | 2009-07-31 | 2011-02-03 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator | 
| LT2473170T (en) | 2009-09-04 | 2019-10-10 | Horizon Orphan Llc | USE OF AEROSOLIZED LEVOFLOXACIN FOR THE TREATMENT OF Cystic Fibrosis | 
| US9016147B2 (en) | 2009-11-03 | 2015-04-28 | Mannkind Corporation | Apparatus and method for simulating inhalation efforts | 
| EP2498848A2 (en) | 2009-11-12 | 2012-09-19 | Stc.Unm | Dry powder inhaler with flutter dispersion member | 
| BR112012033060A2 (en) | 2010-06-21 | 2018-02-27 | Mannkind Corp | Dry powder drug release system methods | 
| MX2012015292A (en) | 2010-06-24 | 2013-05-30 | Gilead Sciences Inc | Pyrazolo [1, 5 -a] pyrimidines as antiviral agents. | 
| US20120027752A1 (en) | 2010-07-22 | 2012-02-02 | Gilead Sciences, Inc. | Methods and compounds for treating paramyxoviridae virus infections | 
| TW201305185A (en) | 2010-09-13 | 2013-02-01 | Gilead Sciences Inc | 2'-fluoro substituted carbon-nucleoside analog for antiviral therapy | 
| JP6050758B2 (en) | 2010-12-07 | 2016-12-21 | レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. | Dry powder inhaler and method of operating the same | 
| WO2012106382A1 (en) | 2011-01-31 | 2012-08-09 | Genoa Pharmaceuticals, Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof | 
| JP6339371B2 (en) | 2011-03-03 | 2018-06-06 | インペル ニューロファーマ インコーポレイテッド | Nasal drug delivery device | 
| AU2012236150B2 (en) | 2011-04-01 | 2016-03-31 | Mannkind Corporation | Blister package for pharmaceutical cartridges | 
| JP6645735B2 (en) | 2011-05-09 | 2020-02-14 | インペル ニューロファーマ インコーポレイテッド | Nose delivery nozzle | 
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles | 
| WO2013016784A1 (en) | 2011-08-04 | 2013-02-07 | Victor Esteve | Dry powder inhaler | 
| AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain | 
| US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents | 
| MX355267B (en) | 2012-03-13 | 2018-04-12 | Gilead Sciences Inc | 2'- substituted carba-nucleoside analogs for antiviral treatment. | 
| PT2838900T (en) | 2012-04-17 | 2019-11-15 | Gilead Sciences Inc | Compounds and methods for antiviral treatment | 
| WO2013184951A2 (en)* | 2012-06-06 | 2013-12-12 | Aerodesigns, Inc. | Aerosol dispenser with replaceable cartridge | 
| SG10201605800UA (en) | 2012-07-12 | 2016-09-29 | Mannkind Corp | Dry powder drug delivery system and methods | 
| US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods | 
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use | 
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use | 
| AU2014228415B2 (en) | 2013-03-15 | 2018-08-09 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods | 
| JP2016520378A (en) | 2013-04-28 | 2016-07-14 | インペル ニューロファーマ インコーポレイテッド | Medical unit dose container | 
| EP3607941A1 (en) | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Dry powder formulations and methods of use | 
| TWI568463B (en) | 2013-07-12 | 2017-02-01 | H 斯圖爾特 坎貝爾 | Mouthpiece for inhalers | 
| BR112015031590B1 (en) | 2013-07-16 | 2021-05-18 | Victor Esteve | powder inhaler | 
| KR102465025B1 (en) | 2013-07-18 | 2022-11-09 | 맨카인드 코포레이션 | Heat-stable dry powder pharmaceutical compositions and methods | 
| US20150044288A1 (en) | 2013-07-31 | 2015-02-12 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof | 
| WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods | 
| UA119050C2 (en) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | PYROL [1.2-f] [1.2.4] TRIASINES USED FOR TREATMENT OF RESPIRATORY-SYNCITAL VIRAL INFECTIONS | 
| NZ722927A (en) | 2014-01-10 | 2022-07-29 | Avalyn Pharma Inc | Aerosol pirfenidone and pyridone analog compounds and uses thereof | 
| JP6701086B2 (en) | 2014-02-20 | 2020-05-27 | オティトピック インコーポレイテッド | Dry powder formulation for inhalation | 
| USD752204S1 (en) | 2014-03-10 | 2016-03-22 | Civitas Therapeutics, Inc. | Indicator for an inhaler | 
| USD755367S1 (en) | 2014-03-10 | 2016-05-03 | Civitas Therapeutics, Inc. | Indicator for an inhaler | 
| USD752734S1 (en) | 2014-03-10 | 2016-03-29 | Civitas Therapeutics, Inc. | Inhaler grip | 
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin | 
| USD748242S1 (en) | 2014-07-11 | 2016-01-26 | H. Stuart Campbell | Inhaler mouthpiece | 
| TWI678369B (en) | 2014-07-28 | 2019-12-01 | 美商基利科學股份有限公司 | Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections | 
| TWI673283B (en) | 2014-08-21 | 2019-10-01 | 美商基利科學股份有限公司 | 2'-chloro aminopyrimidinone and pyrimidine dione nucleosides | 
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler | 
| WO2016115379A1 (en) | 2015-01-14 | 2016-07-21 | Respira Therapeutics, Inc. | Powder dispersion methods and devices | 
| US10874139B2 (en)* | 2015-07-07 | 2020-12-29 | Altria Client Services Llc | E-vapor device including capsule containing pre-vapor formulation | 
| CA2998182A1 (en) | 2015-09-10 | 2017-03-16 | Impel Neuropharma, Inc. | In-line nasal delivery device | 
| US10940274B2 (en) | 2015-12-01 | 2021-03-09 | Cipla Limited | Nasal spray assembly | 
| JP6976970B2 (en)* | 2016-07-07 | 2021-12-08 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | Nicotine inhaler system | 
| US11744967B2 (en) | 2017-09-26 | 2023-09-05 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal delivery devices | 
| FR3072313B1 (en)* | 2017-10-12 | 2019-10-11 | Aptar France Sas | DEVICE FOR DISPENSING FLUID PRODUCT | 
| WO2019104192A1 (en) | 2017-11-21 | 2019-05-31 | Impel Neuropharma, Inc. | Intranasal device with inlet interface | 
| US11571532B2 (en) | 2017-11-21 | 2023-02-07 | Impel Pharmaceuticals Inc. | Intranasal device with dip tube | 
| EP3735244B1 (en) | 2018-01-05 | 2022-11-23 | Impel Pharmaceuticals Inc. | Intranasal delivery of dihydroergotamine by precision olfactory device | 
| WO2019136308A1 (en) | 2018-01-05 | 2019-07-11 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device | 
| JP2021532098A (en) | 2018-07-19 | 2021-11-25 | インペル ニューロファーマ インコーポレイテッド | Respiratory tract delivery of levodopa and dopa decarboxylase inhibitors for the treatment of Parkinson's disease | 
| CN109078245A (en)* | 2018-10-11 | 2018-12-25 | 上海博极给药医药科技有限公司 | A kind of double-capsule type powder inhaler | 
| US11759585B2 (en) | 2019-01-03 | 2023-09-19 | Impel Pharmaceuticals Inc. | Nasal drug delivery device with detachable nozzle | 
| KR20220010011A (en) | 2019-05-17 | 2022-01-25 | 임펠 뉴로파마 인코포레이티드 | Disposable nasal delivery device | 
| PT4081305T (en) | 2019-12-24 | 2024-12-04 | Gilead Sciences Inc | Diacylglycerol kinase modulating compounds | 
| TWI883391B (en) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | Antiviral compounds | 
| TWI874791B (en) | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | Antiviral compounds | 
| TWI791193B (en) | 2020-02-18 | 2023-02-01 | 美商基利科學股份有限公司 | Antiviral compounds | 
| CA3171648A1 (en) | 2020-02-18 | 2021-08-26 | Gilead Sciences, Inc. | Antiviral compounds | 
| CN115698009B (en) | 2020-05-01 | 2025-04-08 | 吉利德科学公司 | CD 73-inhibiting 2, 4-dioxopyrimidine compounds | 
| WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung | 
| JP7654118B2 (en) | 2021-06-23 | 2025-03-31 | ギリアード サイエンシーズ, インコーポレイテッド | Diacylglycerol kinase modulating compounds | 
| EP4359413A1 (en) | 2021-06-23 | 2024-05-01 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds | 
| WO2022271677A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds | 
| JP7651018B2 (en) | 2021-06-23 | 2025-03-25 | ギリアード サイエンシーズ, インコーポレイテッド | Diacylglycerol kinase modulating compounds | 
| WO2023028364A1 (en) | 2021-08-27 | 2023-03-02 | Sepelo Therapeutics, Llc | Targeted compositions and uses therof | 
| EP4422756A1 (en) | 2021-10-29 | 2024-09-04 | Gilead Sciences, Inc. | Cd73 compounds | 
| GB2636208A (en)* | 2023-12-06 | 2025-06-11 | Industrial Design Consultancy Ltd | Powder dispensers | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US2307986A (en)* | 1940-02-15 | 1943-01-12 | Bolte | Insufflator | 
| US2519555A (en)* | 1945-08-31 | 1950-08-22 | Abbott Lab | Sterile medicament insufflator cartridge and insufflator | 
| US2517482A (en)* | 1949-04-09 | 1950-08-01 | Sharp & Dohme Inc | Inhaler | 
| US2581182A (en)* | 1950-03-14 | 1952-01-01 | Abbott Lab | Inhaler | 
| US2946332A (en)* | 1957-12-23 | 1960-07-26 | Nysco Lab Inc | Insufflator | 
| US3669113A (en)* | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device | 
| US3507277A (en)* | 1966-09-17 | 1970-04-21 | Fisons Pharmaceuticals Ltd | Inhalation device | 
| Publication number | Publication date | 
|---|---|
| US3906950A (en) | 1975-09-23 | 
| GB1436813A (en) | 1976-05-26 | 
| DE2415961A1 (en) | 1974-10-17 | 
| FR2224175B1 (en) | 1978-04-14 | 
| BE813143A (en) | 1974-07-31 | 
| FR2224175A1 (en) | 1974-10-31 | 
| CH569486A5 (en) | 1975-11-28 | 
| JPS5048782A (en) | 1975-05-01 | 
| Publication | Publication Date | Title | 
|---|---|---|
| DE7411543U (en) | INHALER FOR POWDERED SUBSTANCES | |
| DE60216265T2 (en) | IMPROVEMENTS IN SPRAY MOUNTS | |
| DE69503883T2 (en) | LIQUID DISPENSER WITH REFILL | |
| DE69206988T2 (en) | Device for injecting a predetermined dose of a medium and method for filling this device | |
| DE69507979T2 (en) | Dispensing pump | |
| DE69304320T2 (en) | BLOOD DETECTION DEVICE | |
| DE60212764T2 (en) | inhaler | |
| EP0827782B1 (en) | Fluid dispenser | |
| DE69712625T2 (en) | discharge | |
| DE2435186A1 (en) | APPLICATION DEVICE FOR POWDERED DRUGS | |
| DE10140704A1 (en) | Process for mixing a poorly soluble pharmaceutical substance with a solvent and syringe to apply the process | |
| DE7434592U (en) | INHALER FOR POWDERED SUBSTANCES | |
| DE19708406A1 (en) | Device for dispensing substances | |
| DE3342407A1 (en) | INJECTION DEVICE | |
| DE2825259C3 (en) | Manually operated liquid atomizer | |
| DE10011120A1 (en) | Media Donor | |
| DE69128720T2 (en) | CORRECTION LIQUID DISPENSER | |
| DE2719815A1 (en) | MEDICAL SYRINGE | |
| DE19622124A1 (en) | Device for applying liquids | |
| DE10323603A1 (en) | Dosing device with a pump device | |
| DE1475172A1 (en) | Dosing and non-dosing aerosol spray head | |
| DE2324296A1 (en) | MIXING CONTAINER FOR DENTAL PREPARATIONS | |
| EP2085147A1 (en) | Device with pressure charged piston for dispensing a multiple syringe or multiple cartridge | |
| DE8621877U1 (en) | Fluid flow regulator for an intravenous delivery device | |
| DE102013113791A1 (en) | donor |